National Institute of Allergy and Infectious Diseases
Link to NIAID Home Page Link to NIAID Home Page Link to NIH Home Page
NIAID Home Health & Science Research Funding Research News & Events Labs at NIAID About NIAID

About NIAID
 Overview
 Organization
  Organizational Charts
  Office of the Director
  DAIDS
  DAIT
  DCR
  DEA
  DIR
  DMID
  VRC
 Director's Page
 Working at NIAID
 Finding People
 Visitor Information


Division of Acquired Immunodeficiency Syndrome (DAIDS)

Vaccine Research Program (VRP)

The discovery and development of an HIV/AIDS vaccine for the prevention of HIV infection is one of the top priorities at the NIAID. As such, the DAIDS Vaccine Research Program (VRP), which is divided into the Preclinical Research and Development Branch and Vaccine Clinical Research Branch, supports basic, preclinical, and clinical research of candidate vaccines through the following activities:

  • Oversees grants, contracts, and cooperative agreements that support preclinical and clinical vaccine research, including the HIV Vaccine Trials Network (HVTN) and Center for HIV/AIDS Immunology (CHAVI)
  • Fosters evaluation of the safety and efficacy of vaccine candidates
  • Promotes research programs to discover novel vaccine strategies for the treatment of HIV
  • Coordinates research activities in consultation and/or collaboration with other government agencies, international organizations, and other Institutes at the National Institutes of Health.
  • Works with the pharmaceutical industry and the Food and Drug Administration to facilitate the evaluation and approval of new vaccines
  • Provides scientific guidance to grantees and contractors

For more information on NIAID’s HIV vaccine research efforts, visit the HIV/AIDS Vaccine Research Area.

back to top


Highlights

Dr. Carl Dieffenbach Appointed Director of the NIAID Division of AIDS
Feb. 1, 2008

News Releases

Statement of Dr. Anthony S. Fauci on the Death of Martin Delaney
Jan. 23, 2009

NIAID Honors AIDS Activist Martin Delaney
Jan. 19, 2009

NIAID Media Availability: Well-Armed Immune Cells Help Long-Term Non-Progressors Contain HIV
Dec. 4, 2008

NIAID Media Availability: World AIDS Day Offers a Reflection on the Past, Hopeful Look to the Future
Nov. 28, 2008

Landmark Study Defines Benefits of Early HIV Testing and Treatment for Infected Infants
Nov. 19, 2008

Special Announcements

Status of NIAID Adenovirus-based Vaccine Studies

Considerations for HIV Vaccine Clinical Trials in Adolescents

Guidance regarding HIV anti-retroviral treatment in developing countries

 
E-mail Icon E-mail this page
Print Icon Print this page

Highlights

Dr. Carl Dieffenbach Appointed Director of the NIAID Division of AIDS
Feb. 1, 2008

News Releases

Statement of Dr. Anthony S. Fauci on the Death of Martin Delaney
Jan. 23, 2009

NIAID Honors AIDS Activist Martin Delaney
Jan. 19, 2009

NIAID Media Availability: Well-Armed Immune Cells Help Long-Term Non-Progressors Contain HIV
Dec. 4, 2008

NIAID Media Availability: World AIDS Day Offers a Reflection on the Past, Hopeful Look to the Future
Nov. 28, 2008

Landmark Study Defines Benefits of Early HIV Testing and Treatment for Infected Infants
Nov. 19, 2008

Special Announcements

Status of NIAID Adenovirus-based Vaccine Studies

Considerations for HIV Vaccine Clinical Trials in Adolescents

Guidance regarding HIV anti-retroviral treatment in developing countries